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ARTICLE Early pregnancy
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background: The increase in miscarriage rate with female age is attributed to a decline in oocyte quality. This age-related decrease of
oocyte quality is accompanied by a decrease in oocyte quantity. Assessment of the number of oocytes by ovarian reserve tests (ORTs) may
therefore also represent their quality. The objective of our study was to assess the predictive value of ORTs for miscarriage in subfertile
women.
methods: This study was a subanalysis within a prospective cohort study of 474 subfertile ovulatory couples in two hospitals in Gronin-
gen, The Netherlands. The ORTs performed were: antral follicle count (AFC), basal and stimulated levels of follicle-stimulating hormone
(FSH) and inhibin B, and the clomiphene citrate challenge test (CCCT). Women who achieved an ongoing pregnancy (n ¼ 233) were com-
pared with women experiencing miscarriage (n ¼ 72) on the results of their ORTs and patient characteristics.
results: In univariate analysis, the outcome of the ORTs did not differ between the groups. Logistic regression analysis including patient
characteristics such as female age did not reveal an association between the ORT results and miscarriage either.
conclusions: Neither AFC, basal and stimulated levels of FSH and inhibin B, nor the CCCT have a statistically signiﬁcant predictive
value for miscarriage in subfertile ovulatory women.
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Introduction
The chance for a woman to have a live birth declines as her age
increases. This is partly due to a diminished chance to conceive, but
mostly caused by an increased chance of (very early) pregnancy loss
(O’Connor et al., 1998). This process of female reproductive ageing
is attributed to a decrease in both oocyte quantity, eventually resulting
in menopause, and oocyte quality (Te Velde and Pearson, 2002). The
main acknowledged manifestation of decreased quality is the occur-
rence of chromosomal abnormalities in the oocyte, leading to aneu-
ploidy in the conceptus, which has been established as the reason
of pregnancy loss in 35–75% of all cases (Baird et al., 2005; Ljunger
et al., 2005; Rai and Regan, 2006).
The quality of a woman’s oocytes cannot be assessed clinically, but
the quantity of the remaining follicle pool can be estimated by
so-called ovarian reserve tests (ORTs). Various studies have suggested
that the quantitative ovarian reserve is predictive for the chance of
miscarriage. An elevated level of basal follicle-stimulating hormone
(FSH), low level of anti-Mu¨llerian hormone (AMH) and low antral fol-
licle count (AFC) have been described to be related to increased mis-
carriage rates (Levi et al., 2001; Elter et al., 2005; Lekamge et al.,
2007). Also, a high incidence of decreased ovarian reserve has been
found among women with unexplained recurrent pregnancy loss
(Trout and Seifer, 2000; Gurbuz et al., 2004). In line with these ﬁnd-
ings are publications suggesting a relationship between decreased
ovarian reserve and chromosomal abnormalities in the conceptus
(Nasseri et al., 1999; Van Montfrans et al., 1999; Freeman et al.,
2000; Kline et al., 2000).
The studies describing an association between quantitative ovarian
reserve and miscarriage or chromosomal abnormalities are challenged
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by a number of comparable studies that do not demonstrate such a
relation (Hofmann et al., 2000; Abdalla and Thum, 2004; Kline
et al., 2004; Van Montfrans et al., 2004; Havryliuk et al., 2006; Luna
et al., 2007; Massie et al., 2007). Furthermore, most of the studies
on this topic are of retrospective design or include small numbers of
subjects. We decided to address the issue in a large prospective
cohort study of subfertile ovulatory women to answer the question
whether ORTs have independent predictive value for the chance of
miscarriage.
Materials and Methods
The present study is part of a prospective cohort study, originally designed
to assess the predictive value of ORTs for spontaneous pregnancy in an
ovulatory subfertile population (Haadsma et al., 2008).
Study population
From December 1999 to July 2003, patients were recruited at the tertiary
fertility centre of the University Medical Center Groningen and the fertility
centre of the Martini Hospital, a teaching hospital, in Groningen, the Neth-
erlands. Patients were asked to participate after a routine subfertility evalu-
ation had been completed. This evaluation included assessment of
ovulation by sonographic cycle analysis and measurement of midluteal pro-
gesterone, semen analysis, post-coital test and hysterosalpingography. The
inclusion criteria for study participation were (i) subfertility for at least 12
months, (ii) a regular ovulatory cycle with midluteal progesterone of .30
nmol/l and a mean cycle length between 21 and 42 days, (iii) at least one
patent tube at hysterosalpingography, (iv) semen analysis with a total
motile count .1  106 and (v) no sexual disorder leading to a coitus fre-
quency of less than once a month. After the basal subfertility evaluation, a
diagnostic laparoscopy was performed if tubal pathology was suspected
clinically (e.g. a history of pelvic inﬂammatory disease), after an abnormal
result of hysterosalpingography or before starting treatment with intrauter-
ine insemination (IUI). Laparoscopy was performed after patients were
asked to participate in this study; if two-sided tubal pathology was
detected, patients were excluded secondarily. Informed consent was
obtained from all participants. The study protocol was reviewed and
approved by the Institutional Research Boards of both participating
hospitals.
Study protocol
After inclusion, patients visited the outpatient clinic in the early follicular
phase of the menstrual cycle (cycle Day 2, 3 or 4). Transvaginal ultrasound
was performed by one of four skilled gynaecologists using a 7.5 MHz
vaginal probe on an Aloka SSD-1700 US machine. Follicles were
counted and measured in two dimensions. The mean of these measure-
ments was taken to be the follicle size. The numbers of follicles sized
2–6 mm from both ovaries were added for the total AFC (Haadsma
et al., 2007). Peripheral blood was drawn to measure basal levels of
FSH and inhibin B. Subsequently, patients self-administered 100 mg clomi-
phene citrate on cycle Day 5–9. One week after the ﬁrst visit, blood
samples were drawn again to measure stimulated FSH and inhibin B
levels. The result of the clomiphene citrate challenge test (CCCT) was
deﬁned as the sum of the values for basal and stimulated FSH.
Hormone assays
For measurements of concentrations of FSH and inhibin B, serum was
stored at 2208C until processing. Serum FSH levels were measured by
ﬂuorimmunometric determination on the AutoDelﬁa (Wallac/Perkin
Elmer, Turku, Finland). For FSH, the inter-assay coefﬁcient of variation
was 3.7% and the sensitivity was ,0.05 IU/l. The lower limit of detection
was 0.03 IU/l. The standard of the FSH assay was calibrated against the
WHO Second International Reference Preparation for human FSH (78/
549). Inhibin B concentrations were assayed with Enzyme Immunoassay
(ELISA) from Serotec (Kidlington, Oxford, UK). The inter-assay coefﬁcient
of variation for inhibin B was 11% and the sensitivity was ,10 pg/ml. The
lower limit of detection was 5 pg/ml.
Follow-up
After completion of the basal subfertility evaluation, expectant manage-
ment or treatment was proposed to each couple. The advice was based
on duration of subfertility and the estimated chances for spontaneous con-
ception according to the prediction model routinely used in both clinics at
the time of study (Eimers et al., 1994). Couples were advised to start
treatment if the estimated chance to conceive was below 30% or duration
of subfertility exceeded 3 years (2 years in case of female age 37 years).
Couples who were primarily advised expectant management and did not
conceive spontaneously were also offered treatment as soon as they met
these criteria. The kind of treatment offered to the couples with a low
chance of spontaneous conception depended on the type of subfertility.
Patients were offered treatment by IUI with stimulation, in case of unex-
plained subfertility and mild male factor, or IUI without stimulation, in
case of cervical factor, up to a maximum of six cycles. If IUI treatment
failed, couples were offered in vitro fertilization (IVF) treatment, generally
up to a maximum of three cycles because of the reimbursement policy
of the medical insurance companies. If semen quality was insufﬁcient for
IUI, couples were advised treatment with IVF or intracytoplasmic sperm
injection (ICSI). Treatment was not generally available for women over
the age of 40.
Follow-up started on the day of the ﬁrst ORT. Data on pregnancies and
treatment were recorded. Information was obtained from medical ﬁles
and from questionnaires completed by the participating couples.
Couples were followed until a pregnancy leading to a live birth was
achieved, either after spontaneous conception or after treatment. For
the non-pregnant couples, follow-up ended after fertility treatment was
fully completed. Couples who never started treatment or withdrew
from treatment received a questionnaire to complete data. Follow-up
also ended when couples started contraceptives or ended their relation-
ship. The last date of follow-up was 1 November 2006. All couples who
achieved a pregnancy during the follow-up period were identiﬁed. For
each couple, only the ﬁrst pregnancy during follow-up was taken into
account. Ongoing pregnancies and miscarriages were selected for analysis.
An ongoing pregnancy was deﬁned as a viable intrauterine pregnancy of at
least 16 weeks gestation. A miscarriage was deﬁned as a pregnancy loss
between 4 and 16 weeks amenorrhoea, with the exception of conﬁrmed
extra-uterine pregnancies or artiﬁcially terminated pregnancies. Time to
pregnancy was deﬁned as the period between the ﬁrst ORT and the
ﬁrst day of the last menstrual cycle. Assisted conception was deﬁned as
conception after treatment with IVF or ICSI as opposed to spontaneous
conception or conception after IUI. Female age and duration of subfertility
were scored on the ﬁrst day of the last menstrual cycle. For the other
characteristics, values at the time of the ﬁrst ORT were used when
applicable.
Statistical analysis
To analyse the relationship between ORTs and pregnancy outcome, we
performed univariate and multivariate analyses. The univariate analyses
compared the miscarriage group to the ongoing pregnancy group with
respect to ORTs and patient characteristics, including subfertility features.
For this we used the chi-square test, Mann–Whitney U-test and Student’s
t-test when applicable. The multivariate analysis included logistic regression
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with miscarriage status as the outcome and the ORTs and patient charac-
teristics as predictors. To explore the nature of the relationship with mis-
carriage of each of the continuous predictors, we used basic spline
functions (Harrell, 2001). In this way, the possibility of a linear and non-
linear relationship of each of the variables and miscarriage was assessed,
including the presence of threshold points above or below which miscar-
riage rates changed. The effect of the variables was described as odds
ratios (OR) with 95% conﬁdence intervals (CI). A P-value 0.05 was con-
sidered statistically signiﬁcant. Data were analysed with SPSS 14.0 (SPSS
Inc., Chicago, IL, USA) and S-plus 7.0 (MathSoft Inc., Seattle, WA, USA).
Results
From the 474 couples included in the prospective cohort study, 320
(67.5%) conceived during follow-up (Fig. 1). Of these, 305 of the 320
pregnant couples were selected for analysis. Of these, 233 had an
ongoing pregnancy and 72 experienced miscarriage. Fig. 1 also pre-
sents the reasons for exclusion. The grounds for artiﬁcial termination
were once, congenital abnormalities of a fetus with normal karyotype
and once, personal reasons. The group of 15 excluded couples did
not differ from the selected 305 couples with respect to patient
characteristics and results of the ORTs (data not shown). Of the
305 selected couples, 132 (43%) conceived spontaneously, 94
(31%) after IUI, 36 (12%) after IVF and 43 (14%) after ICSI. Of the
132 couples that conceived spontaneously, 37 (28%) had already
started therapy and conceived in between treatment cycles or after
discontinuing treatment. Of the 154 non-pregnant couples, 19
were lost to follow-up, 14 ended their relationship and 13 started
contraceptives during the study period. Median follow-up for the
154 non-pregnant couples was 24.8 months (10th–90th percentiles
2.7–46.9 months).
Table I presents a univariate comparison of patient characteristics
and results of the ORTs of the groups with ongoing pregnancy and
miscarriage. The miscarriage group was older and had more often
conceived through ART. Logistic regression with splines revealed a
statistically signiﬁcant non-linear association of BMI with miscarriage
which could be simpliﬁed to a piecewise linear relation: up to a BMI
of 32 no change in miscarriage rate was observed, but from a BMI
of 32 onwards the probability of miscarriage increased. For none of
the ORTs, a relation with miscarriage could be demonstrated, both
in analyses with and without correction for possible confounders.
The best ﬁtting model for miscarriage included female age (OR per
year 1.06; 95% CI 0.99–1.14), assisted conception (OR yes to no
1.95; 95% CI 1.02–3.75) and BMI above 32 (OR per kg/m2 1.57;
95% CI 1.12–2.21). The c-statistic (area under the receiver–operator
curve) for this model was 0.65.
Discussion
The present study shows that basal and stimulated FSH, the CCCT,
basal and stimulated inhibin B and AFC all have no statistically signiﬁ-
cant predictive value for the chance of miscarriage in a population of
subfertile ovulatory women.
This ﬁnding is surprising as a decreased quantitative ovarian reserve
is considered to be a reﬂection of advanced ovarian ageing and ovarian
ageing is clearly associated with an increased rate of fetal aneuploidy
and miscarriage. A possible explanation may be that ORTs basically
relate to the number of remaining oocytes and that their quantity is
unrelated to their quality. Oocyte quality might predominantly be
determined by biological damage accumulated over time and would
thus not be related to the number of oocytes left, but mainly to
female age (Tarin, 1995; Eichenlaub-Ritter, 1998). This hypothesis is
compatible with recent publications demonstrating that female age
does predict pregnancy chances, both spontaneous and after assisted
conception, but ORTs do not (Broekmans et al., 2006; Maheshwari
et al., 2006; Van Rooij et al., 2006; Van der Steeg et al., 2007).
Also, young women who respond poorly to ovarian stimulation
during IVF treatment appear to have clearly better prospects than
their older counterparts (Hanoch et al., 1998; Saldeen et al., 2007).
Alternatively, it has been hypothesized that a biological relation
between quantity and quality of oocytes does exist. The so-called
production-line theory states that the germ cells produced earliest
during fetal life are the least prone to non-disjunction. These
oocytes are selected for ovulation ﬁrst, leaving the oocytes of lesser
quality for later years (Henderson and Edwards, 1968;
Eichenlaub-Ritter, 1998). The reason that ORTs do not predict mis-
carriage could hence be that these tests do not accurately reﬂect
oocyte quantity. For instance, an elevated FSH level may indeed be
due to a decreased number of follicles, but also to a range of other
causes including the presence of heterophylic antibodies or
Figure 1: Flowchart of eligible patients.
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FSH-receptor polymorphisms (Lambalk and De Koning, 1998; De
Koning et al., 2000, 2006). Especially when the relation between
oocyte quantity and quality is subtle, inaccurate estimation of quanti-
tative ovarian reserve might obscure this relation. Finally, the etiology
of miscarriage is known to be diverse. If any, ovarian reserve is only
one of many contributing factors.
Another possible explanation for the absence of a relation between
ovarian reserve and the chance of miscarriage in our population is that
the relation between oocyte quantity and quality does exist, but only
at the very end of the reproductive period, when ovarian reserve is
severely diminished. For that reason, we also analysed the extremes
in our population separately, but in this manner we did not ﬁnd an
indication for a relation between ORTs and miscarriage either. For
example, 5% of our population had a basal FSH level of 12 IU/l
(n ¼ 15); 4 of these women (27%) miscarried compared with 23%
in the population with FSH ,12 IU/l (P ¼ 0.73). However, women
with a severely decreased ovarian reserve were not likely to be
included in our study population, since they often have irregular and
anovulatory cycles, which was an exclusion criterion in our study. In
general, we cannot exclude the possibility that the relation between
ovarian reserve and miscarriage does exist, but was not discovered
in our subfertile study population, since differences between the
various ORT values may have been too small.
Our ﬁndings that miscarriage rates are increased with higher BMI
and after conception through ART have been described before
(Wang et al., 2004; Metwally et al., 2008). Furthermore, we found
no effect of male factor on miscarriage rate, which minimizes the
possibility that a relation between ovarian reserve and miscarriage
was obscured by the inclusion of couples with male factor subfertility.
Next to analysing a relation between total motile semen count and
miscarriage, we assessed the semen parameters volume, concen-
tration, percentage motile sperm and percentage sperm of normal
morphology and found no linear or non-linear relation between
these factors and miscarriage either (data not shown). However,
since one of the inclusion criteria of our study was a total motile
semen count of at least one million, our results do not exclude the
possibility that a very low semen quality actually does inﬂuence the
miscarriage risk.
Limitations
The present study is part of a prospective cohort study, which was
originally designed to assess the predictive value of ORTs for the
chance of spontaneous pregnancy; no power analysis was performed
(Haadsma et al., 2008). However, three acknowledged predictive
factors for miscarriage were identiﬁed in our study (female age, BMI
............................................................... ...............................................................
.............................................................................................................................................................................................
Table I Patient characteristics and results of ovarian reserve tests according to pregnancy outcome
Ongoing pregnancy (n 5 233) Miscarriage (n5 72) P-value
Median (*No.) 10th–90th percentiles (*%) Median (*No.) 10th–90th percentiles (*%)
Patient characteristics
Age (years) 32.4 27.0–38.1 34.2 28.0–39.6 ,0.01
Body mass index (kg/m2) 22.8 19.4–30.1 22.9 19.5–33.2 0.82
Smoking habit* 61 28.4% 16 27.1% 0.85
Duration of subfertility (years) 3.3 1.9–5.8 3.4 1.9–5.4 0.51
Primary subfertility* 162 69.5% 52 72.2% 0.79
Previous miscarriage* 35 15.1% 14 19.4% 0.35
Mean cycle length (days) 28 26–33 28 25–32 0.52
Semen analysis (TMC, 106) 38.6 4.1–179.8 33.6 4.1–205.0 0.85
Diagnostic category of subfertility* 0.76
Unexplained 125 53.6% 35 48.6%
Male factor 99 42.2% 34 47.2%
Cervical factor 9 3.9% 3 4.2%
Time to pregnancy (months) 8.8 1.2–28.4 10.6 0.8–34.4 0.22
Conception after ART* 52 22.3% 27 37.5% 0.01
Results of ovarian reserve tests
Antral follicle count (n) 11 5–23 11 5–22 0.86
Basal FSH (IU/l) (bFSH) 6.3 4.5–9.6 6.3 4.6–10.1 0.71
Stimulated FSH (IU/l) (sFSH) 6.2 3.9–10.7 6.5 4.2–9.7 0.56
CCCT (bFSHþsFSH)(IU/l) 12.9 9.0–19.6 12.8 9.1–19.6 0.71
Basal inhibin B (ng/l) 89.0 40.1–144.9 79.0 30.0–132.0 0.14
Stimulated inhibin B (ng/l) 230.0 98.0–144.9 238.5 113.2–416.8 0.98
TMC, total motile count; ART, assisted reproductive technology (including in vitro fertilization and intracytoplasmic sperm injection); FSH, follicle-stimulating hormone; CCCT, clomiphene
citrate challenge test.
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and assisted conception), which minimizes the chance that a major
relation between ORTs and miscarriage was missed. Yet, the size of
our study population might have been too small to detect a more
subtle relationship between ORTs and miscarriage. To indicate the
size of the effect of the ORTs on miscarriage risk, we chose the
example of basal FSH. In order to be able to provide CI, we dichot-
omized basal FSH and included it in the best ﬁtting model (consisting
of age, BMI and conception with or without ART). For example, using
FSH ¼ 8 IU/l as threshold point, the effect was an OR 1.03 with a
95% CI of 0.48–2.2 and P ¼ 0.95. Please note that our analysis of
the relation between the ORTs and miscarriage was more reﬁned
than shown in this example as we explored the possible linear and
non-linear nature of the relationship as well.
The results of most ORTs may vary per cycle in the same woman,
especially basal FSH and the CCCT (Scott et al., 1990; Kwee et al.,
2004; Hendriks et al., 2005; De Koning et al., 2008). In our study,
all ORTs were only performed once per participant. It is not known
whether repeating these tests would enhance their predictive value
for miscarriage in subfertile populations. However, in a prospective
study among fertile women, Van Montfrans et al. (2004) could not
show a relation between repeatedly measured basal FSH and the
chance of miscarriage.
In our study, we did not measure AMH, which is nowadays a prom-
ising ORT (Van Rooij et al., 2005; Visser et al., 2006). Since AMH was
not such an acknowledged ORT at the start of the study in 1999, we
did not perform this test and unfortunately no serum was stored.
Finally, it has been demonstrated that the shorter the duration of
pregnancy before miscarriage, the higher the probability that the
loss is caused by aneuploidy (Boue et al., 1985; Hassold et al., 1996;
Hassold and Hunt, 2001). We deﬁned miscarriage as pregnancy loss
between 4 and 16 weeks, which is a wide deﬁnition, including late
pregnancy loss. In addition, we cannot exclude that we missed
several very early pregnancy losses since couples did not routinely
perform a pregnancy test every month. Early biochemical pregnancy
loss was most likely to be detected in patients receiving ART, since
it is usual (though not obligatory) in our IVF clinic to perform a preg-
nancy test after each ART cycle. This might partly explain the predic-
tive value of assisted conception for miscarriage in our population.
Comparison with other studies
Three small retrospective studies suggest a relation between ORTs
and miscarriage. Levi et al. found 20 miscarriages among 28 pregnant
women with highly elevated basal FSH levels, which is a signiﬁcantly
increased miscarriage rate (71%) compared with a large control
group with normal FSH levels (Levi et al., 2001). Levi et al. included
all subfertile women who visited their clinic, also women with irregular
cycles who had possibly already entered menopausal transition. Elter
et al. compared 28 women who miscarried with 34 women who deliv-
ered a healthy baby after ICSI treatment. AFC proved to have predic-
tive value for miscarriage, while female age, basal FSH and estradiol
values did not (Elter et al., 2005). Most interestingly, Lekamge et al.
demonstrated a signiﬁcantly higher miscarriage rate amongst IVF-
treated women with low levels of AMH (5/17, 29.4%) compared
with women with high AMH levels (6/36, 16.7%) (Lekamge et al.,
2007). These results are of special interest since their study population
was not at risk for severely decreased ovarian reserve: among their
inclusion criteria were a basal FSH level ,10 IU/l and a proven ovu-
latory cycle. The ﬁndings of Lekamge et al. have not yet been con-
ﬁrmed or rejected in other studies.
Among the publications supporting our ﬁndings is a prospective
study of Van Montfrans et al. performed in women who were over
30 years of age without a history of subfertility, and pursuing a spon-
taneous pregnancy (Van Montfrans et al., 2004). Of the 86 pregnant
women, 41 (48%) had a miscarriage, including very early pregnancy
loss. No relationship between miscarriage and basal FSH level was
found. Luna et al. performed a retrospective study within an IVF popu-
lation. The miscarriage rate in the group with elevated basal FSH levels
was 22.9% (11/48), similar to the controls with normal FSH (19.3%,
226/1169) (Luna et al., 2007). Abdalla and Thum also retrospectively
evaluated miscarriage rates in an IVF population, selecting the
outcome of the ﬁrst IVF cycle, and found no differences between
various groups when divided by three different threshold levels for
basal FSH (Abdalla and Thum, 2004).
Clinical implications
The relation between oocyte quantity and oocyte quality is widely dis-
cussed, but not agreed on (yet). Therefore caution is required when
using ORTs and interpreting ‘abnormal’ results. The present study
shows that ORTs have no predictive value for miscarriage in a subfer-
tile ovulatory population. AMH may prove an exception but was not
evaluated in our study. The results of our study are in line with studies
showing no predictive value of ORTs for spontaneous and assisted
conception in subfertile populations. Since the ORTs evaluated in
this study have no apparent predictive value for both the chance to
conceive and pregnancy outcome, we recommend not using them
in the general subfertile ovulatory population, not only to avoid
unnecessary testing itself, but also to avoid unsupported interpretation
of their results.
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